Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basal-bolus intensification with glulisine added to glargine plus oral agents in poorly controlled type 2 diabetes
2005-002614-38Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2006
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of human insulin, insulin glargine, glimepiride and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sanofi. Primary endpoint: Primary efficacy endpoint. Started Sep 2006; status: completed.
02
Drugs
human insulininsulin glargineglimepiridemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-002614-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002614-38.